Branded drugs are
patented drugs. When a pharmaceutical company discovers a new drug, it files
for a patent. Branded generics are generic versions of products sold either by
the original manufacturer of the patented drug or by generic manufacturers that
build up brand equity for their generic versions of the medication, which they
introduce right after the patent expires on the original product.
Branded generics,
sometimes also called as ‘value-added generics ‘that can either be a novel
dosage form of an original patented drug or a generic drug with a definite
trade name. Branded generics differ from ‘commodity generics’ which are
pharmaceutical products, generally used as an alternative to innovator product
after the expiry of the patent. The global branded generics market is projected
to grow gradually as large number of pharmaceutical products are going to go
off patent within the forecast period of 2014 to 2025.
To request a
sample copy or view summary of this report, click the link below:
The global branded
generics market is predictable to grow significantly as large number of
pharmaceutical products are going to be off patent within the forecast period.
Simple marketing authorization procedures, entry of new players, changing
medicine practices, greater profit margin are some other factors which are
projected to increase the global branded generics market. Though, huge
competition from branded drugs and commodity generic products are some of the
restrain factors.
The global branded
generics market size spans product type, application, distribution channel
type, and region. On the basis of product type, the global market size spans
Value-Added Branded Generics, Trade (Brand) Named Generics. Value added branded
generics: are usually developed using innovative pharmaceutical technologies
and such products allowing the goal of the products being more patient-friendly
to be achieved. It must meet all the requirements of bio-equivalency and have
the same quality, efficacy and safety as the original drug.
See More
Reports of This Category:
About
Grand View Research:
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
No comments:
Post a Comment